Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis

Background: Rare genetic variants are emerging as important contributors to the heritability of multiple sclerosis (MS). Whether rare variants also contribute to pediatric-onset multiple sclerosis (POMS) is unknown. Objective: To test whether genes harboring rare variants associated with adult-onset...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis 2023-04, Vol.29 (4-5), p.505-511
Hauptverfasser: Horton, Mary K, Shim, Joan E, Wallace, Amelia, Graves, Jennifer S, Aaen, Gregory, Greenberg, Benjamin, Mar, Soe, Wheeler, Yolanda, Weinstock-Guttman, Bianca, Waldman, Amy, Schreiner, Teri, Rodriguez, Moses, Tillema, Jan-Mendelt, Chitnis, Tanuja, Krupp, Lauren, Casper, T Charles, Rensel, Mary, Hart, Janace, Quach, Hong L, Quach, Diana L, Schaefer, Catherine, Waubant, Emmanuelle, Barcellos, Lisa F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Rare genetic variants are emerging as important contributors to the heritability of multiple sclerosis (MS). Whether rare variants also contribute to pediatric-onset multiple sclerosis (POMS) is unknown. Objective: To test whether genes harboring rare variants associated with adult-onset MS risk (PRF1, PRKRA, NLRP8, and HDAC7) and 52 major histocompatibility complex (MHC) genes are associated with POMS. Methods: We analyzed DNA samples from 330 POMS cases and 306 controls from the US Network of Pediatric MS Centers and Kaiser Permanente Northern California for which Illumina ExomeChip genotypes were available. Using the gene-based method “SKAT-O,” we tested the association between candidate genes and POMS risk. Results: After correction for multiple comparisons, one adult-onset MS gene (PRF1, p = 2.70 × 10−3) and two MHC genes (BRD2, p = 5.89 × 10−5 and AGER, p = 7.96 × 10−5) were significantly associated with POMS. Results suggest these are independent of HLA-DRB1*1501. Conclusion: Findings support a role for rare coding variants in POMS susceptibility. In particular, rare minor alleles within PRF1 were more common among individuals with POMS compared to controls while the opposite was true for rare variants within significant MHC genes, BRD2 and AGER. These genes would not have been identified by common variant studies, emphasizing the merits of investigating rare genetic variation in complex diseases.
ISSN:1352-4585
1477-0970
DOI:10.1177/13524585221150736